App-Quantinova.ai

Blood Glucose Monitoring: Which is Better: Continuous Real-Time or Episodic Real-Time on Demand? PRO

Revital Nimri - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Type 2 Diabetes Mellitus in Adolescence

Thomas Reinehr - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Polycystic Ovary Syndrome

Metformin Hydrochloride

C-Peptide Levels and Glycaemic Control in Children, Adolescents, and Young Adults with Type 1 Diabetes

Maria Xatzipsalti - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Circulating miRNA Expression Profile in Pregestational and Gestational Obesity

Judit Bassols - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Link Between BMI and Insulin Requirement in Children and Young People with Type 1 Diabetes Mellitus

Swathi Upadrasta - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Evaluation of Glucose Metabolism and Cardiovascular Risk Factors and Hyperandrogenemia in Prepubertal Girls with Premature Pubarche

Digdem Bezen - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Androgen Tear

Is Reduced Heart Rate Variability Associated with Arterial Stiffness in Youth with Childhood-Onset Type 1 Diabetes Mellitus?

Hwa Young Kim - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Type 1 Diabetes Onset: A Story of Innate and Adaptive Immune Cells?

Ana Laura Fitas - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Effect of 6 Months Therapy with Metreleptin in an African American Boy with Congenital Generalised Lipodystrophy

Svetlana Ten - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acanthosis Nigricans

Metreleptin

Evaluation of Ability of Urinary Podocalyxin, Nephrin and Liver type Fatty Acid Binding Protein for Early Diagnosis in Renal Injury in Adolescents with Type 1 Diabetes

Seniha Kiremitci Yilmaz - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Is Metabolic Control Affected by Military Service in Young Adults with Type 1 Diabetes?

Avivit Brener - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic ketoacidosis

N/A

Influence of Nocturnal Glycaemia on Ventricular Repolarisation and Heart Rate Variability in Prepubertal Children with Type 1 Diabetes

Marie-Beatrice Saade - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Sclerostin and Its Associations with Energy Metabolism in Children and Adolescents

Anna Wedrychowicz - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Ergocalciferol

Diabetes Mellitus and Hypoparathyroidism in a Girl with Mitochondrial Disease

Gonul Buyukyilmaz - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

Calcitriol

Brachial Flow Mediated Dilation and its Relation to Osteoprotegerin in Type 1 Diabetes Mellitus

Eman Sherief - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Can We Rely on Finger Stick Haemoglobin A1c? Comparison of Levels Assayed by DCA 2000 with IFCC Reference Method in a Paediatric Cohort

Gianluca Tornese - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Cardiac Autonomic Neuropathy is Highly Predictive for Survival in Children with Mauriac Syndrome

Margarita Arshinkova - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

N/A

Adherence to Diabetes Care in Children and Adolescents with Type 1 Diabetes Mellitus in Spain: Results from the Chrystal Study

Juan Pedro Lopez Siguero - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Importance of Thrombocyte Volume Parameters in Type 1 Diabetes Mellitus Patients with and without Clinical Findings of Diabetic Ketoacidosis

Dogus Vuralli - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Increased Arterial Wall Stiffness in Children with Type 1 Diabetes and Poor Metabolic Control: An Early Marker of Vascular Complications?

Barbora Obermannova - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Masked hypertension

N/A

Filters

4759 Abstracts